Medical research

How the nervous system controls tumor growth

(Medical Xpress)—From the time it first comes online during development the nervous system begins to exact precise control over many biologic functions. In some cases, too much control. When it does, a little nerve-squelching ...

Medical research

High blood sugar levels 'reprogram' stem cells

High levels of glucose in the blood "reprogrames" stem cells, leading to a lasting increase in the risk of developing dangerous atherosclerosis, according to research funded by the British Heart Foundation published today ...

Neuroscience

Scientists record powerful signal in the brain's white matter

The human brain is made up of two kinds of matter: the nerve cell bodies (gray matter), which process sensation, control voluntary movement, and enable speech, learning and cognition, and the axons (white matter), which connect ...

Medical research

Research uncovers potential health risks of travel to Mars

Sending a manned mission to Mars requires more than a powerful launch rocket. Prep work also includes learning how a three-year space flight could affect the human body. With funding from the National Aeronautics and Space ...

Oncology & Cancer

CAR T, immunotherapy bring new hope for multiple myeloma patients

Two investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the treatment of multiple myeloma patients who had relapsed and were resistant to other ...

Immunology

Immune cells in the intestine have a sweet tooth

A new study led by Marc Veldhoen, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) and Associate Professor at Faculdade de Medicina de Lisboa (FMUL) and published today in the scientific ...

Immunology

Patients' own cells could be the key to treating Crohn's disease

A new technique using patients' own modified cells to treat Crohn's disease has been proven to be effective in experiments using human cells, with a clinical trial of the treatment expected to start in the next six months.

page 6 from 40